Genesis Healthcare, Inc. (GENN) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
GENN, $ (piyasa değeri 0) fiyatla Healthcare işi olan Genesis Healthcare, Inc.'i temsil ediyor. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 46/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 16 Mar 2026Genesis Healthcare, Inc. (GENN) Sağlık ve Boru Hattı Genel Bakışı
Genesis Healthcare, Inc. provides skilled nursing and rehabilitation services across the United States, operating a network of facilities and offering specialized medical services. Facing competitive pressures and regulatory changes, the company focuses on delivering inpatient and rehabilitation services to a diverse patient base.
Yatırım Tezi
Genesis Healthcare operates in a challenging environment, reflected in its negative profit margin of -1.5%. The company's gross margin stands at 42.2%. Key value drivers include its extensive network of facilities and the demand for skilled nursing and rehabilitation services. Growth catalysts involve expanding rehabilitation services and optimizing facility operations. Potential risks include regulatory changes, reimbursement pressures, and competition from other healthcare providers. Investors should monitor the company's ability to improve profitability and navigate the evolving healthcare landscape. The company's beta of -1.21 suggests a negative correlation to market movements.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Operates approximately 341 skilled nursing facilities and assisted/senior living communities across 24 states as of December 31, 2020.
- Provides rehabilitation therapy services to approximately 1,400 healthcare locations in 42 states, the District of Columbia, and China.
- Profit margin of -1.5% indicates ongoing challenges in achieving profitability.
- Gross margin of 42.2% reflects the company's ability to manage direct costs effectively.
- Employs approximately 44,000 individuals, highlighting its significant role as an employer in the healthcare sector.
Rakipler & Benzerleri
Güçlü Yönler
- Extensive network of facilities.
- Comprehensive range of services.
- Established presence in multiple states.
- Experienced management team.
Zayıflıklar
- Negative profit margin.
- High debt levels.
- Exposure to regulatory changes.
- Dependence on government reimbursement programs.
Katalizörler
- Ongoing: Expansion of rehabilitation services to new geographic markets and healthcare settings.
- Ongoing: Strategic partnerships and acquisitions to expand service offerings and geographic reach.
- Ongoing: Technology integration and innovation to improve operational efficiency and patient care.
- Ongoing: Focus on value-based care models to improve patient outcomes and reduce costs.
- Ongoing: Development of specialty programs to cater to specific patient populations and healthcare needs.
Riskler
- Potential: Increasing competition from other healthcare providers.
- Potential: Rising labor costs and staffing shortages.
- Potential: Changes in government reimbursement policies.
- Potential: Economic downturns and reduced consumer spending.
- Ongoing: Regulatory changes and compliance requirements.
Büyüme Fırsatları
- Expansion of Rehabilitation Services: Genesis Healthcare can expand its rehabilitation therapy services to new geographic markets and healthcare settings. The market for rehabilitation services is projected to grow as the population ages and the demand for post-acute care increases. By leveraging its existing infrastructure and expertise, Genesis Healthcare can capture a larger share of this market, potentially increasing revenue by 10-15% over the next three years.
- Strategic Partnerships and Acquisitions: Genesis Healthcare can pursue strategic partnerships and acquisitions to expand its service offerings and geographic reach. Collaborating with hospitals, physician groups, and other healthcare providers can enhance patient referrals and improve care coordination. Acquiring smaller skilled nursing facilities and assisted living communities can provide access to new markets and patient populations, driving revenue growth and market share gains.
- Technology Integration and Innovation: Investing in technology and innovation can improve operational efficiency, enhance patient care, and reduce costs. Implementing electronic health records (EHRs), telehealth solutions, and remote monitoring devices can streamline workflows, improve communication, and enable more personalized care. These technologies can also help Genesis Healthcare attract and retain patients, improve patient satisfaction, and reduce hospital readmission rates.
- Focus on Value-Based Care: Shifting towards value-based care models can improve patient outcomes, reduce costs, and enhance reimbursement rates. By participating in accountable care organizations (ACOs) and other value-based payment arrangements, Genesis Healthcare can align its incentives with those of payers and providers. This can lead to increased patient referrals, improved care coordination, and higher reimbursement rates, driving revenue growth and profitability.
- Development of Specialty Programs: Genesis Healthcare can develop specialty programs to cater to specific patient populations and healthcare needs. Examples include programs for patients with Alzheimer's disease, Parkinson's disease, and other chronic conditions. By offering specialized care and services, Genesis Healthcare can attract patients with complex medical needs and differentiate itself from competitors. This can lead to increased patient referrals, higher reimbursement rates, and improved patient outcomes.
Fırsatlar
- Expansion of rehabilitation services.
- Strategic partnerships and acquisitions.
- Technology integration and innovation.
- Focus on value-based care.
Tehditler
- Increasing competition.
- Rising labor costs.
- Changes in reimbursement policies.
- Economic downturns.
Rekabet Avantajları
- Extensive network of skilled nursing and assisted living facilities.
- Established relationships with healthcare providers and payers.
- Comprehensive range of rehabilitation therapy services.
- Experience in providing care to diverse patient populations.
GENN Hakkında
Genesis Healthcare, Inc., founded in 2003 and headquartered in Kennett Square, Pennsylvania, is a major provider of skilled nursing and assisted living services in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and Other Services. Its Inpatient Services segment includes a network of approximately 341 skilled nursing facilities and assisted/senior living communities across 24 states as of December 31, 2020. The Rehabilitation Therapy Services segment offers physical therapy, occupational therapy, speech-language pathology, and respiratory therapy. These services are provided to approximately 1,400 healthcare locations in 42 states, the District of Columbia, and China. The Other Services segment provides physician, staffing, and other healthcare-related services. Genesis Healthcare was formerly known as FC-GEN Operations Investment, LLC, changing its name in February 2015. The company's focus is on providing comprehensive care and rehabilitation services to patients requiring skilled nursing and assisted living support.
Ne Yaparlar
- Owns and operates skilled nursing facilities.
- Operates assisted/senior living facilities.
- Provides inpatient services.
- Offers rehabilitation therapy services (physical, occupational, speech).
- Supplies respiratory therapy services.
- Offers physician staffing services.
- Provides other healthcare-related services.
İş Modeli
- Generates revenue from inpatient services provided at skilled nursing and assisted living facilities.
- Earns revenue from rehabilitation therapy services offered to patients in various healthcare settings.
- Receives payments from Medicare, Medicaid, and private insurance companies.
- Provides staffing and other healthcare-related services to generate additional revenue.
Sektör Bağlamı
Genesis Healthcare operates within the medical care facilities industry, which is influenced by factors such as an aging population, increasing demand for long-term care services, and evolving regulatory requirements. The industry is competitive, with key players including ACORQ, CHCR, GDBYF, GNBT, and MGFRF. Market trends include a growing emphasis on value-based care, the integration of technology to improve patient outcomes, and the expansion of home-based care services. Genesis Healthcare's position is defined by its extensive network of facilities and its focus on providing comprehensive rehabilitation and skilled nursing services.
Kilit Müşteriler
- Individuals requiring skilled nursing care.
- Seniors needing assisted living services.
- Patients requiring rehabilitation therapy.
- Hospitals and healthcare facilities needing rehabilitation and respiratory therapy services.
Finansallar
Grafik & Bilgi
Genesis Healthcare, Inc. (GENN) hisse senedi fiyatı: Price data unavailable
Son Haberler
GENN için son haber bulunmamaktadır.
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
GENN için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
GENN için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, GENN'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: David Sheridan Harrington
CEO
David Sheridan Harrington serves as the CEO of Genesis Healthcare, overseeing the operations of a large healthcare organization with approximately 44,000 employees. His background includes extensive experience in healthcare management and leadership. He is responsible for setting the strategic direction of the company, managing its financial performance, and ensuring the delivery of high-quality care to patients. Harrington's leadership is focused on driving innovation, improving operational efficiency, and enhancing patient outcomes.
Sicil: Under David Sheridan Harrington's leadership, Genesis Healthcare has focused on navigating the challenges of the healthcare industry, including regulatory changes and reimbursement pressures. Key milestones include efforts to expand rehabilitation services and improve facility operations. His strategic decisions aim to enhance the company's financial performance and ensure the long-term sustainability of its business model.
GENN OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that Genesis Healthcare may not meet the minimum financial standards or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited financial reporting, making it more difficult for investors to assess their financial health and operational performance. Trading on the OTC Other tier typically involves higher risks compared to exchanges like NYSE or NASDAQ due to the lack of stringent listing requirements and regulatory oversight.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure and transparency.
- Higher price volatility due to lower trading volume.
- Potential for fraud or manipulation.
- Lack of regulatory oversight and investor protection.
- Going concern risk due to financial distress.
- Verify the company's financial statements and SEC filings.
- Assess the company's business model and competitive landscape.
- Evaluate the company's management team and corporate governance practices.
- Review the company's risk factors and legal disclosures.
- Check for any regulatory actions or investigations.
- Monitor the company's news and press releases.
- Consult with a financial advisor before investing.
- Established history of operations in the healthcare sector.
- Presence of experienced management team.
- Network of skilled nursing and assisted living facilities.
- Provision of essential healthcare services.
- Compliance with regulatory requirements.
GENN Hakkında Sıkça Sorulan Sorular
GENN için değerlendirilmesi gereken temel faktörler nelerdir?
Genesis Healthcare, Inc. (GENN) şu anda yapay zeka skoru 46/100, düşük puanı gösteriyor. Temel güçlü yan: Extensive network of facilities.. İzlenmesi gereken birincil risk: Potential: Increasing competition from other healthcare providers.. Bu bir finansal tavsiye değildir.
GENN MoonshotScore'u nedir?
GENN şu anda MoonshotScore'da 46/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
GENN verileri ne sıklıkla güncellenir?
GENN fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler GENN hakkında ne diyor?
GENN için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
GENN'a yatırım yapmanın riskleri nelerdir?
GENN için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Increasing competition from other healthcare providers.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
GENN'ın P/E oranı nedir?
GENN için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için GENN'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
GENN aşırı değerli mi, yoksa düşük değerli mi?
Genesis Healthcare, Inc. (GENN)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
GENN'ın temettü verimi nedir?
Genesis Healthcare, Inc. (GENN) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Information is based on available data as of December 31, 2020.
- OTC market data may be limited and less reliable than exchange-listed stocks.
- AI analysis pending for GENN.